Sympatholytics: Alpha-2 agonists

24,641views

Sympatholytics: Alpha-2 agonists

Watch later

Watch later

Hypokalemia: Clinical
Movement of water between body compartments
The role of the kidney in acid-base balance
Blood histology
Blood components
Respiratory acidosis
Metabolic acidosis
Respiratory alkalosis
Metabolic alkalosis
Metabolic and respiratory alkalosis: Clinical
Metabolic and respiratory acidosis: Clinical
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Chronic obstructive pulmonary disease (COPD): Clinical
Chronic obstructive pulmonary disease (COPD): Nursing process (ADPIE)
Adrenergic antagonists: Alpha blockers
Sympatholytics: Alpha-2 agonists
Alpha-2 adrenergic agonists: Nursing pharmacology
Adrenergic receptors
Adrenergic antagonists: Beta blockers
Diabetes mellitus: Clinical
Diabetes mellitus (DM): Nursing process (ADPIE)
Diabetes mellitus
Diabetes mellitus: Pathology review
Stroke: Nursing process (ADPIE)
Stroke: Clinical
Ischemic stroke
Intracerebral hemorrhage
Peptic ulcers and stomach cancer: Clinical
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Sickle cell disease (NORD)
Sickle cell disease: Nursing process (ADPIE)
Sickle cell disease: Clinical
Blood groups and transfusions
Erythropoietin
Blood products: Nursing pharmacology
Oxygen binding capacity and oxygen content
Blood products and transfusion: Clinical
Hemophilia
Hemophilia: Nursing process (ADPIE)
Leukemia: Nursing process (ADPIE)
Chronic leukemia
Leukemias: Pathology review
Acute leukemia
Leukemia: Clinical
Lymphomas: Pathology review
Lymphoma: Clinical
Non-Hodgkin lymphoma
Hodgkin lymphoma
Lymphatic system anatomy and physiology
Anatomy of the abdominal viscera: Liver, biliary ducts and gallbladder
Liver anatomy and physiology
Cirrhosis
Cirrhosis: Pathology review
Cirrhosis: Clinical
Cirrhosis: Nursing process (ADPIE)
Hepatitis C virus
Hepatitis A and Hepatitis E virus
Liver cancer: Nursing
Cholestatic liver disease
Non-alcoholic fatty liver disease
HIV (AIDS)
HIV and AIDS: Pathology review
Antiretrovirals for HIV/AIDS - Protease inhibitors: Nursing pharmacology
Antiretrovirals for HIV/AIDS - NRTIs and NNRTIs: Nursing pharmacology
Antiretrovirals for HIV/AIDS - Integrase strand transfer inhibitors: Nursing pharmacology
Anatomy of the abdominal viscera: Pancreas and spleen
Pancreatitis: Nursing process (ADPIE)
Glaucoma: Nursing process (ADPIE)
Glaucoma
Eye conditions: Refractive errors, lens disorders and glaucoma: Pathology review
Acute respiratory distress syndrome (ARDS): Nursing
Anatomy of the coronary circulation
Coronary artery disease: Pathology review
Coronary artery disease: Clinical
ECG basics
ECG normal sinus rhythm
ECG rate and rhythm
ECG axis
ECG intervals
ECG QRS transition
ECG cardiac infarction and ischemia
Cardiac cycle
Arterial disease
Delirium
Dementia and delirium: Clinical
Vascular dementia
Frontotemporal dementia
Dementia with Lewy bodies
Dementia: Pathology review
Tumor lysis syndrome (TLS): Nursing Process (ADPIE)
Cholelithiasis: Nursing
Coronary artery disease (CAD) and angina pectoris: Nursing process (ADPIE)
Breast cancer: Nursing process (ADPIE)
Ovarian cancer: Nursing
Cervical cancer: Nursing
Hormones and hormone modulators for cancer: Nursing pharmacology
Endometriosis: Nursing
Heart failure
Left-sided heart failure: Nursing process (ADPIE)
Heart failure: Pathology review
Pneumonia: Pathology review
Pneumonia
Bacterial pneumonia: Nursing process (ADPIE)
Respiratory stimulants: Nursing pharmacology
Corticosteroids - Inhaled: Nursing pharmacology
Pneumothorax and hemothorax: Nursing
Chest trauma: Clinical
Pleural effusion: Nursing
Tuberculosis (TB): Nursing
Parkinson disease: Nursing process (ADPIE)
Huntington disease
Multiple sclerosis (MS): Nursing
Multiple sclerosis
Guillain-Barré syndrome: Nursing
Guillain-Barre syndrome
Myasthenia gravis: Nursing
Acute kidney injury (AKI): Nursing process (ADPIE)
Acute kidney injury: Clinical
Chronic kidney disease (CKD): Nursing
Chronic kidney disease
Chronic kidney disease: Clinical
Polycystic kidney disease (PKD): Nursing
Renin-angiotensin-aldosterone system
Osteoarthritis: Nursing
Osteoarthritis
Rheumatoid arthritis (RA): Nursing process (ADPIE)
Rheumatoid arthritis: Clinical
Rheumatoid arthritis
Rheumatoid arthritis and osteoarthritis: Pathology review
Systemic lupus erythematosus
Systemic lupus erythematosus (SLE): Pathology review
Systemic lupus erythematosus (SLE): Clinical
Systemic lupus erythematosus (SLE): Nursing
Mycobacterium tuberculosis (Tuberculosis)
Peripheral venous disease (PVD): Nursing process (ADPIE)
Peripheral arterial disease (PAD): Nursing process (ADPIE)
Buerger disease: Nursing
Raynaud phenomenon: Nursing
Aortic dissections and aneurysms: Pathology review
Aortic aneurysms and dissections: Clinical
Aortic dissection
Aortic aneurysm: Nursing process (ADPIE)
Venous thromboembolism (VTE): Nursing process (ADPIE)
Benign prostatic hyperplasia (BPH): Nursing process (ADPIE)
Benign prostatic hyperplasia
Prostate cancer: Nursing
Prostate cancer
Testicular cancer: Nursing
Testicular cancer
Diabetic ketoacidosis (DKA): Nursing process (ADPIE)
Endocrine system anatomy and physiology
Vitamin B12 deficiency
Thalassemia: Nursing
Anemia - Iron-deficiency: Nursing
Anemia - Macrocytic: Nursing
Anemia - Aplastic: Nursing
Thyroid hormones
Medications for thyroid disorders: Nursing pharmacology
Hyperthyroidism: Nursing process (ADPIE)
Hypothyroidism: Nursing process (ADPIE)
Hypoparathyroidism: Nursing
Hyperparathyroidism: Nursing
Anxiety disorders: Nursing process (ADPIE)
Spinal cord injury (SCI): Nursing
Cluster A personality disorders
Smoke inhalation injury: Nursing process (ADPIE)
Shock - Anaphylactic: Nursing
Shock - Obstructive: Nursing
Shock - Neurogenic: Nursing
Shock - Hypovolemic: Nursing
Shock - Cardiogenic: Nursing
Shock - Septic: Nursing
Pulmonary edema: Nursing
Burn injury: Nursing

Transcript

Watch video only

Central anti-adrenergics are a class of medications that’s not very commonly used these days. Their mechanism of action is to target the adrenergic neurons in the central nervous system, and prevent them from effectively releasing the catecholamines: norepinephrine and epinephrine.

So, the nervous system is divided into the central nervous system, so the brain and spinal cord; and the peripheral nervous system, which includes all the nerves that connect the central nervous system to the muscles and organs. The peripheral nervous system can be divided into the somatic nervous system, which controls voluntary movement of our skeletal muscles; and the autonomic nervous system, which controls the involuntary movement of smooth muscles and glands of our organs.

Now, the autonomic nervous system - which includes both the sympathetic and parasympathetic nervous systems - is made up of a relay that includes two neurons. We’ll focus on just the sympathetic nervous system. Signals for the autonomic nervous system start in the hypothalamus, at the base of the brain. Hypothalamic neurons have really long axons that carry signals all the way down to the thoracic and lumbar spinal cord nuclei, where they synapse with preganglionic neuron cell bodies. Here, they release the neurotransmitter norepinephrine, which causes the preganglionic neurons to transmit the signals down their relatively short axon, which exits the central nervous system via the spinal cord. These short nerve fibers reach the nearby sympathetic ganglion, which consists of many postganglionic neuron cell bodies. The postganglionic neurons are also called adrenergic neurons, because they release the neurotransmitter norepinephrine, which is also called noradrenaline; and to a much lesser degree, epinephrine, or adrenaline. These two catecholamines activate the adrenergic receptors on many different organs, which allow the sympathetic nervous system to trigger the fight or flight response that increases the heart rate and blood pressure, as well as slowing digestion. All of this maximizes blood flow to the muscles and brain, and can help you either run away from a threat, or fight it, which is why it’s also called the “fight or flight response.”

Alright, so let’s zoom into the synapse between the hypothalamic neurons and the preganglionic neurons, which can be found throughout the brainstem and spinal cord. The presynaptic terminal contains loads of tiny synaptic vesicles, each of which stores thousands of norepinephrine molecules. But for norepinephrine to be there in the first place, a precursor amino acid, called tyrosine, is taken up by the adrenergic neuron and gets converted to L-dihydroxyphenylalanine, or L-DOPA for short, by an enzyme called tyrosine hydroxylase. Next, L-DOPA is converted by an enzyme called DOPA decarboxylase to dopamine, which is then packaged into the synaptic vesicles. The remaining dopamine will be broken down by a class of enzymes called monoamine oxidases, or MAOs for short. Okay, now once inside the vesicles, dopamine get converted into norepinephrine. And then, whenever the appropriate signal travels down the axon to the axon terminal, these vesicles fuse with the presynaptic membrane in order for norepinephrine to get released (or exocytosed) into the synaptic cleft and take action on the adrenergic receptors of the postsynaptic neuronal membrane. Okay, but this release of norepinephrine is controlled through negative feedback inhibition. So when a pre-synaptic nerve terminal is stimulated to release a bunch of norepinephrine in the synapse, some of it will bind to a special type of receptor called an alpha-2 adrenergic receptor, located on the presynaptic membrane. These alpha-2 receptors then inhibit further release of norepinephrine into the synapse, so the postsynaptic neuron doesn’t get over stimulated.

Alright, so medications that act on adrenergic neurons of the brainstem to inhibit adrenergic signal transmission are called central anti-adrenergics. What these do, is collectively oppose the effects of the sympathetic nervous system. So overall, the heart rate and blood pressure decrease, digestive processes speed up, and the fight-or-flight response gets blocked.

Key Takeaways

Alpha-2 agonists are a class of drugs that bind to alpha-2 adrenergic receptors and activate them, resulting in a range of physiological effects. Alpha-2 adrenergic receptor agonists include clonidine, guanabenz, and guanfacine. These medications stimulate alpha-2 adrenergic receptors on the presynaptic neurons in the CNS, especially those in the medulla. This decreases the release of norepinephrine in the sympathetic neurons, which leads to lower blood pressure. Alpha-2 agonists are used to treat various conditions such as anxiety, depression, attention deficit hyperactivity disorder (ADHD), and pain. Common side effects associated with the use of alpha-2 agonists include dry mouth, constipation, headache, dizziness, drowsiness, and fatigue.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "G-Protein–Coupled Receptors in Heart Disease" Circulation Research (2018)
  5. "α2A- and α2C-Adrenoceptors as Potential Targets for Dopamine and Dopamine Receptor Ligands" Molecular Neurobiology (2018)
  6. "Alpha-2 Adrenergic Receptor Agonists: A Review of Current Clinical Applications" Anesthesia Progress (2015)
  7. "Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial" The Lancet (2019)